X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39) 39
male (32) 32
oncology (29) 29
middle aged (27) 27
adult (26) 26
aged (23) 23
chemotherapy (22) 22
female (21) 21
index medicus (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
cancer (15) 15
survival (12) 12
treatment outcome (12) 12
life sciences (11) 11
prognosis (11) 11
aged, 80 and over (10) 10
combined modality therapy (10) 10
metastasis (10) 10
adolescent (9) 9
disease-free survival (9) 9
survival analysis (9) 9
analysis (8) 8
follow-up studies (8) 8
hematology (8) 8
neoplasm metastasis (8) 8
neoplasm staging (8) 8
prognostic factors (8) 8
prostate cancer (8) 8
therapy (8) 8
trial (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
france (7) 7
hematology, oncology and palliative medicine (7) 7
prostatic neoplasms - drug therapy (7) 7
radiotherapy (7) 7
retrospective studies (7) 7
taxoids - administration & dosage (7) 7
antineoplastic agents - therapeutic use (6) 6
mitoxantrone (6) 6
pharmacology & pharmacy (6) 6
risk factors (6) 6
transplantation, autologous (6) 6
young adult (6) 6
air intakes for jet-propulsion plants (5) 5
androgen antagonists - therapeutic use (5) 5
blasting (5) 5
bone marrow transplantation (5) 5
bone-marrow transplantation (5) 5
combustion engines (5) 5
controlling fuel supply in air-breathing jet-propulsion plants (5) 5
docetaxel (5) 5
drug administration schedule (5) 5
engine plants in general (5) 5
gas-turbine plants (5) 5
heating (5) 5
hematopoietic stem cell transplantation (5) 5
hot-gas or combustion-product engine plants (5) 5
lighting (5) 5
machines or engines in general (5) 5
mechanical engineering (5) 5
multiple myeloma - drug therapy (5) 5
non-positive displacement machines or engines, e.g. steamturbines (5) 5
prednisone - administration & dosage (5) 5
prospective studies (5) 5
steam engines (5) 5
weapons (5) 5
adjuvant chemotherapy (4) 4
age factors (4) 4
antineoplastic agents - adverse effects (4) 4
disease progression (4) 4
etoposide - administration & dosage (4) 4
high-dose chemotherapy (4) 4
human health and pathology (4) 4
indexing scheme for aspects relating tonon-positive-displacement machines or engines, gas-turbines orjet-propulsion plants (4) 4
indexing schemes relating to engines or pumps in varioussubclasses of classes f01-f04 (4) 4
men (4) 4
proportional hazards models (4) 4
prostatic neoplasms - mortality (4) 4
prostatic neoplasms - pathology (4) 4
salvage therapy (4) 4
taxoids - adverse effects (4) 4
time factors (4) 4
urology & nephrology (4) 4
[ sdv ] life sciences [q-bio] (3) 3
adenocarcinoma - drug therapy (3) 3
androgen antagonists - administration & dosage (3) 3
animals (3) 3
carcinoma (3) 3
carcinoma, renal cell - drug therapy (3) 3
care and treatment (3) 3
clinical trials (3) 3
cyclophosphamide (3) 3
cyclophosphamide - administration & dosage (3) 3
dose-response relationship, drug (3) 3
doxorubicin (3) 3
estramustine - administration & dosage (3) 3
etoposide (3) 3
guidelines (3) 3
health aspects (3) 3
hodgkin disease - therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 2, pp. 149 - 158
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1442 - 1450
Summary Background Poor prognosis germ-cell tumours are only cured in about half of patients. We aimed to assess whether treatment intensification based on an... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST CYCLE | ETOPOSIDE | THERAPY | SOUTHWEST-ONCOLOGY-GROUP | CISPLATIN | ONCOLOGY | DENSE CHEMOTHERAPY | HIGH-DOSE CHEMOTHERAPY | COMPLETE-RESPONSE | CANCER | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Peritoneal Neoplasms - blood | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Neoplasms, Germ Cell and Embryonal - blood | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Young Adult | Mediastinal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Oxaliplatin | Chorionic Gonadotropin - blood | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Paclitaxel - administration & dosage | Precision Medicine | alpha-Fetoproteins - metabolism | Peritoneal Neoplasms - pathology | Lenograstim | Mediastinal Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - mortality | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Peritoneal Neoplasms - mortality | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Ifosfamide - administration & dosage | International Agencies | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Testicular Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - pathology | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Tumors | Cancer | Analysis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 787 - 794
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 5, pp. 417 - 427
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 68, Issue 2, pp. 196 - 204
Journal Article
European Urology, ISSN 0302-2838, 05/2018, Volume 73, Issue 5, pp. 696 - 703
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e12577 - e12577
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 2/2011, Volume 60, Issue 2, pp. 261 - 271
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 50, Issue 5, pp. 953 - 962
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2005, Volume 23, Issue 15, pp. 3343 - 3351
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e15598 - e15598
Journal Article